Maintenance agreement for (2) illumina nextseq 2000 sequencers.
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00118
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $93,351
Award facts
- Contract value 100% obligated
- $93,351.36 Current and potential, with all options
- Completion date 55% complete
- Current and potential, with all options
- Funding agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $93,351.36 firm fixed-price purchase order to Illumina, Inc. on April 1, 2026, for a two-year maintenance agreement covering two NextSeq 2000 sequencers located at the agency's Bethesda, Maryland facility. The contract, which extends through March 31, 2027, represents a standard service and support engagement for Illumina's widely-deployed genetic sequencing instruments across the federal research enterprise. No set-aside designation was applied to this award, reflecting Illumina's specialized position as the manufacturer of these proprietary sequencing systems.
Illumina serves as a primary technology provider for genomic research and diagnostics across the National Institutes of Health and related civilian agencies, with the National Cancer Institute leveraging the company's NextSeq platforms to support cancer research, genomic profiling, and diagnostic initiatives. This maintenance agreement ensures continued operational support and system performance for critical laboratory infrastructure supporting the Institute's research mission. The award aligns with Illumina's broader federal contracting portfolio, which includes substantial indefinite delivery contracts with the U.S. Department of Agriculture ($45 million) and ongoing task orders across multiple agencies, positioning the company as a foundational supplier of next-generation sequencing capabilities throughout the federal government.
Quick answers
Who was awarded contract 75N98026P00118?
75N98026P00118 was awarded to Illumina, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on April 1, 2026.
How much is contract 75N98026P00118 worth?
The government has obligated $93,351 on 75N98026P00118.
Which agency awarded contract 75N98026P00118?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00118, with funding from National Cancer Institute (National Institutes of Health).
Was contract 75N98026P00118 competed?
The extent of competition for 75N98026P00118 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award